BRPI0311182A2 - método para isolar uma célula endotelial e método para realizar provas cruzadas específicas para o doador - Google Patents

método para isolar uma célula endotelial e método para realizar provas cruzadas específicas para o doador

Info

Publication number
BRPI0311182A2
BRPI0311182A2 BRPI0311182A BR0311182A BRPI0311182A2 BR PI0311182 A2 BRPI0311182 A2 BR PI0311182A2 BR PI0311182 A BRPI0311182 A BR PI0311182A BR 0311182 A BR0311182 A BR 0311182A BR PI0311182 A2 BRPI0311182 A2 BR PI0311182A2
Authority
BR
Brazil
Prior art keywords
isolating
endothelial cell
tests
specific cross
donor
Prior art date
Application number
BRPI0311182A
Other languages
English (en)
Inventor
Suchitra Sumitran-Holgersson
Original Assignee
Absorber Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Absorber Ab filed Critical Absorber Ab
Publication of BRPI0311182A2 publication Critical patent/BRPI0311182A2/pt

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56966—Animal cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/475—Assays involving growth factors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
    • G01N2333/71—Assays involving receptors, cell surface antigens or cell surface determinants for growth factors; for growth regulators
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/24—Immunology or allergic disorders
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/24—Immunology or allergic disorders
    • G01N2800/245—Transplantation related diseases, e.g. graft versus host disease
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Cell Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Food Science & Technology (AREA)
  • Zoology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Measuring And Recording Apparatus For Diagnosis (AREA)
BRPI0311182A 2002-05-16 2003-05-16 método para isolar uma célula endotelial e método para realizar provas cruzadas específicas para o doador BRPI0311182A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US38103302P 2002-05-16 2002-05-16
PCT/IB2003/002502 WO2003098212A2 (en) 2002-05-16 2003-05-16 Method of isolating an endotehelial cell and method of donor specific crossmatching

Publications (1)

Publication Number Publication Date
BRPI0311182A2 true BRPI0311182A2 (pt) 2016-06-21

Family

ID=29550055

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0311182A BRPI0311182A2 (pt) 2002-05-16 2003-05-16 método para isolar uma célula endotelial e método para realizar provas cruzadas específicas para o doador

Country Status (17)

Country Link
US (3) US8173372B2 (pt)
EP (1) EP1458853B1 (pt)
AT (1) ATE449838T1 (pt)
AU (1) AU2003241107B2 (pt)
BR (1) BRPI0311182A2 (pt)
CA (1) CA2486119C (pt)
CY (1) CY1109815T1 (pt)
DE (1) DE60330223D1 (pt)
DK (1) DK1458853T3 (pt)
ES (1) ES2337244T3 (pt)
IL (2) IL165250A0 (pt)
NO (1) NO20040174L (pt)
NZ (1) NZ537220A (pt)
PL (2) PL397820A1 (pt)
PT (1) PT1458853E (pt)
SI (1) SI1458853T1 (pt)
WO (1) WO2003098212A2 (pt)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8986944B2 (en) 2001-10-11 2015-03-24 Aviva Biosciences Corporation Methods and compositions for separating rare cells from fluid samples
US8980568B2 (en) 2001-10-11 2015-03-17 Aviva Biosciences Corporation Methods and compositions for detecting non-hematopoietic cells from a blood sample
NZ537220A (en) * 2002-05-16 2008-06-30 Absorber Ab Method of isolating an endothelial cell and method of donor specific crossmatching
CN101583722A (zh) 2006-07-14 2009-11-18 阿维瓦生物科学股份有限公司 从生物学样品检测稀有细胞的方法和组合物
EP2051076A1 (en) * 2007-10-18 2009-04-22 Koninklijke Philips Electronics N.V. Interaction of probe molecules and cells as a diagnostic marker
AU2021210669A1 (en) 2020-01-24 2022-08-18 Pfizer Inc. Anti-E-selectin antibodies, compositions and methods of use

Family Cites Families (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4352883A (en) 1979-03-28 1982-10-05 Damon Corporation Encapsulation of biological material
US4353888A (en) 1980-12-23 1982-10-12 Sefton Michael V Encapsulation of live animal cells
NO155316C (no) 1982-04-23 1987-03-11 Sintef Fremgangsmaate for fremstilling av magnetiske polymerpartikler.
US4714680B1 (en) * 1984-02-06 1995-06-27 Univ Johns Hopkins Human stem cells
US5130144B1 (en) 1984-02-06 1995-08-15 Univ Johns Hopkins Human stem cells and monoclonal antibodies
US4965204A (en) 1984-02-06 1990-10-23 The Johns Hopkins University Human stem cells and monoclonal antibodies
US5026365A (en) 1987-04-29 1991-06-25 The University Of Massachusetts Method and apparatus for therapeutically treating immunological disorders and disease states
ES2035317T5 (es) 1987-11-09 1998-03-16 Becton Dickinson Co Metodo para analizar celulas hematopoyeticas en una muestra.
US5158881A (en) 1987-11-17 1992-10-27 Brown University Research Foundation Method and system for encapsulating cells in a tubular extrudate in separate cell compartments
US5283187A (en) 1987-11-17 1994-02-01 Brown University Research Foundation Cell culture-containing tubular capsule produced by co-extrusion
US5071741A (en) 1988-04-18 1991-12-10 Cryolife, Inc. Cryoprotective agent and its use in cryopreservation of cellular matter
DE3829752A1 (de) 1988-09-01 1990-03-22 Akzo Gmbh Integrale asymmetrische polyaethersulfonmembran, verfahren zur herstellung und verwendung zur ultrafiltration und mikrofiltration
DE3829766A1 (de) 1988-09-01 1990-03-22 Akzo Gmbh Verfahren zur herstellung von membranen
US5084350A (en) 1990-02-16 1992-01-28 The Royal Institution For The Advance Of Learning (Mcgill University) Method for encapsulating biologically active material including cells
US5061620A (en) 1990-03-30 1991-10-29 Systemix, Inc. Human hematopoietic stem cell
US5283058A (en) 1990-08-30 1994-02-01 The General Hospital Corporation Methods for inhibiting rejection of transplanted tissue
HK1001832A1 (en) 1991-04-25 1998-07-10 Brown University Research Foundation Implantable biocompatible immunoisolatory vehicle for delivery of selected therapeutic products
US5257984A (en) 1991-10-02 1993-11-02 Norfolk Scientific, Inc. Blood collector
US5955291A (en) * 1992-01-09 1999-09-21 Alitalo; Kari Antibodies recognizing tie receptor tyrosine kinase and uses thereof
CA2128527A1 (en) 1992-01-21 1993-07-22 Raymond P. Goodrich, Jr. Method of freezing cells and cell-like materials
US5518890A (en) 1992-11-20 1996-05-21 Mccormick & Company, Inc. Method and apparatus for the quantitation and separation of contaminants from particulate materials
JP4098355B2 (ja) 1993-08-12 2008-06-11 ニューロテック ユーエスエー， インコーポレイテッド 遺伝的に改変された細胞を含む生体適合性免疫隔離カプセル
US5518878A (en) 1993-09-15 1996-05-21 Organogenesis Inc. Cryopreservation of cultured skin or cornea equivalents with agitation
US5482841A (en) 1994-05-24 1996-01-09 Sangstat Medical Corporation Evaluation of transplant acceptance
US6017719A (en) * 1994-06-14 2000-01-25 Nexell Therapeutics, Inc. Positive and positive/negative cell selection mediated by peptide release
US5840502A (en) * 1994-08-31 1998-11-24 Activated Cell Therapy, Inc. Methods for enriching specific cell-types by density gradient centrifugation
US5580714A (en) 1995-03-08 1996-12-03 Celox Laboratories, Inc. Cryopreservation solution
US5629145A (en) 1995-03-24 1997-05-13 Organ, Inc. Cryopreservation of cell suspensions
KR0176513B1 (ko) * 1995-04-13 1999-04-15 김광호 자기 기록/재생장치
US5942385A (en) * 1996-03-21 1999-08-24 Sugen, Inc. Method for molecular diagnosis of tumor angiogenesis and metastasis
US5843633A (en) * 1996-04-26 1998-12-01 Amcell Corporation Characterization of a human hematopoietic progenitor cell antigen
AU4659697A (en) 1996-10-03 1998-04-24 Regents Of The University Of California, The Cryopreservation of human adult and fetal pancreatic cells and human platelets
US6103536A (en) 1997-05-02 2000-08-15 Silver Lake Research Corporation Internally referenced competitive assays
EP0893493A3 (de) * 1997-07-21 2002-12-04 Aventis Pharma Deutschland GmbH Genetisch veränderte Zellen und deren Verwendung in der Prophylaxe oder Therapie von Erkrankungen
US20030100107A1 (en) 1998-05-29 2003-05-29 Thomas Jefferson University Compositions and methods for generating differentiated human cells
US6376653B1 (en) 1998-09-28 2002-04-23 Smithkline Beecham Plc Tie2 antagonist antibodies
US6197294B1 (en) 1998-10-26 2001-03-06 Neurotech S.A. Cell surface molecule-induced macrophage activation
US6309643B1 (en) 1999-04-30 2001-10-30 The Regents Of The University Of California IBD-associated microbial antigens and methods of using same
GB0015923D0 (en) * 2000-06-30 2000-08-23 Astrazeneca Ab Methods
US6984308B2 (en) * 2001-03-06 2006-01-10 Cincinnati Children's Hospital Research Foundation Electrochemical analysis of coenzyme Q10 and reduced coenzyme Q10
ES2299590T3 (es) * 2001-08-10 2008-06-01 Imclone Systems, Inc. Uso medico de celulas madre que expresan vegfr-1.ng vegfr-1.
AU2002365261A1 (en) * 2001-10-18 2003-09-02 The Children's Hospital Of Philadelphia Methods and materials for the recruitment of endothelial cells
NZ537220A (en) * 2002-05-16 2008-06-30 Absorber Ab Method of isolating an endothelial cell and method of donor specific crossmatching
DE602005012962D1 (de) * 2004-08-13 2009-04-09 Medtronic Inc Isolation der endothelvorläuferzellen-untermengen und verfahren zu ihrer verwendung

Also Published As

Publication number Publication date
PL397820A1 (pl) 2012-07-16
SI1458853T1 (sl) 2010-04-30
IL165250A0 (en) 2005-12-18
US20030228638A1 (en) 2003-12-11
PL212661B1 (pl) 2012-11-30
US8173372B2 (en) 2012-05-08
EP1458853A2 (en) 2004-09-22
US8034635B2 (en) 2011-10-11
PT1458853E (pt) 2010-02-23
AU2003241107A1 (en) 2003-12-02
WO2003098212A3 (en) 2004-07-01
PL373564A1 (en) 2005-09-05
ATE449838T1 (de) 2009-12-15
IL165250A (en) 2011-03-31
CA2486119C (en) 2011-01-04
EP1458853B1 (en) 2009-11-25
WO2003098212A2 (en) 2003-11-27
NO20040174L (no) 2004-03-08
US20090142780A1 (en) 2009-06-04
ES2337244T3 (es) 2010-04-22
AU2003241107B2 (en) 2009-09-03
CY1109815T1 (el) 2014-09-10
DK1458853T3 (da) 2010-04-06
NZ537220A (en) 2008-06-30
WO2003098212B1 (en) 2004-07-29
DE60330223D1 (pt) 2010-01-07
CA2486119A1 (en) 2003-11-27
US20050244404A1 (en) 2005-11-03

Similar Documents

Publication Publication Date Title
DE60232234D1 (de) Verfahren zur kultivierung von circovirus
DE602005027168D1 (de) Batterie, Verfahren zur deren Herstellung und Verfahren zum Prüfen von Elektrolytverlust
NO20033396D0 (no) Forbedret in vitro fremgangsmåte for kultivering av mammale celler for autolog celle implantasjon/transplantasjon fremgangsmåter
ZA200509760B (en) Composition for maintaining organ and cell viability
CY1110337T1 (el) Παρασκευη πρεγκαμπαλινης και σχετικων ενωσεων
ATE407138T1 (de) Verfahren zur herstellung interferierender rna- moleküle in säugetierzellen und therapeutische anwendungen solcher moleküle
PL1863905T3 (pl) Sposób aktywacji naturalnych komórek zabójców preparatami komórek guza in vitro
WO2007017915A3 (en) Use of common ϝ chain cytokines for the visualization, isolation and genetic modification of memory t lymphocytes.
WO2006127809A3 (en) Methods for expansion and analysis of cultured hematopoietic stem cells
CY1109815T1 (el) Μεθοδοι διασταυρουμενης συμβατοτητας ειδικες δοτη
DE60307615D1 (de) Zellkulturmedium
ATE526394T1 (de) Verfahren zur expansion von cd4+ cd25+ t regulatory zellen
DE60232322D1 (de) Verfahren
WO2004013288A3 (en) Methods and kits for synthesis of sirna expression cassettes
ATE514784T1 (de) Zellpräparation
DE602005019156D1 (de) Verfahren zur auswertung von ribonukleotidsequenzen
DK1537229T3 (da) Fremgangsmåder til produktion af biologiske stoffer i pigmentmanglende mutanter af Bacillus-celler
ATE406461T1 (de) Rna-bioassay
TW200510011A (en) A method for regeneration of bone
AU2003260815A8 (en) Method for the rapid assessment of the presence and viability of bacterial cells and use thereof________________________
WO2004016743A3 (en) Culturing anaplasma
WO2004010852A3 (en) Tissue compositions and methods for producing same
WO2003087305A3 (en) Methods and compositions for anchoring stem cells in a microenvironment
ATE431554T1 (de) Stammzellen, verfahren zu deren reinigung, identifizierung und verwendung
AU2003237703A1 (en) Methods of obtaining isoform specific expression in mammalian cells

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE AS 11A, 12A E 13A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2384 DE 13-09-2016 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.

B15K Others concerning applications: alteration of classification

Ipc: G01N 33/569 (2006.01)